Goodrich Katherine has filed 6 insider transactions across 1 company since November 2024.
Most recent transaction: a option exercise of 2233 shares of Tarsus Pharmaceuticals, Inc. ($TARS) on December 15, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Goodrich Katherine | Director | M | Common Stock | 2233 | $0.00 | 2,233.0000 | 42,607,717 | 9999.99% | 0.01% |
| Dec. 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Goodrich Katherine | Director | M | Restricted Stock Units | 2233 | $0.00 | 4,467.0000 | 42,607,717 | 33.33% | 0.01% |
| June 12, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Goodrich Katherine | Director | A | Stock Option (right to buy) | 4540 | $0.00 | 4,540.0000 | 37,604,538 | 9999.99% | 0.01% |
| June 12, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Goodrich Katherine | Director | A | Restricted Stock Units | 2954 | $0.00 | 2,954.0000 | 37,604,538 | 9999.99% | 0.01% |
| Nov. 13, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Goodrich Katherine | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 38,381,968 | 9999.99% | 0.03% |
| Nov. 13, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Goodrich Katherine | Director | A | Restricted Stock Units | 6700 | $0.00 | 6,700.0000 | 38,381,968 | 9999.99% | 0.02% |